- Home
- IAG vs RGC Comparison
IAG vs RGC Comparison
Compare IAG & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IAG | RGC |
|---|---|---|
| Founded | 1990 | 2014 |
| Country | Canada | Hong Kong |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 11.5B |
| IPO Year | 2002 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IAG | RGC |
|---|---|---|
| Price | $19.92 | $29.11 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.75 | N/A |
| AVG Volume (30 Days) | ★ 6.8M | 174.8K |
| Earning Date | 05-05-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $44.84 | N/A |
| Revenue Next Year | $1.33 | N/A |
| P/E Ratio | $18.66 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.34 | $9.39 |
| 52 Week High | $24.87 | $950.00 |
Technical Indicators
Market Signals| Indicator | IAG | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 53.96 | 54.24 |
| Support Level | $16.07 | $22.43 |
| Resistance Level | $22.47 | $37.83 |
| Average True Range (ATR) | 0.91 | 3.55 |
| MACD | 0.31 | 0.36 |
| Stochastic Oscillator | 82.51 | 35.65 |
Price Performance
Historical ComparisonAbout IAG Iamgold Corporation
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.